Literature DB >> 19644859

Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis.

Michael P M van der Linden1, Anouk L Feitsma, Saskia le Cessie, Marlena Kern, Lina M Olsson, Soumya Raychaudhuri, Ann B Begovich, Monica Chang, Joseph J Catanese, Fina A S Kurreeman, Jessica van Nies, Désirée M van der Heijde, Peter K Gregersen, Tom W J Huizinga, René E M Toes, Annette H M van der Helm-Van Mil.   

Abstract

OBJECTIVE: The severity of joint destruction in rheumatoid arthritis (RA) is highly variable from patient to patient and is influenced by genetic factors. Genome-wide association studies have enormously boosted the field of the genetics of RA susceptibility, but risk loci for RA severity remain poorly defined. A recent meta-analysis of genome-wide association studies identified 6 genetic regions for susceptibility to autoantibody-positive RA: CD40, KIF5A/PIP4K2C, CDK6, CCL21, PRKCQ, and MMEL1/TNFRSF14. The purpose of this study was to investigate whether these newly described genetic regions are associated with the rate of joint destruction.
METHODS: RA patients enrolled in the Leiden Early Arthritis Clinic were studied (n=563). Yearly radiographs were scored using the Sharp/van der Heijde method (median followup 5 years; maximum followup 9 years). The rate of joint destruction between genotype groups was compared using a linear mixed model, correcting for age, sex, and treatment strategies. A total of 393 anti-citrullinated protein antibody (ACPA)-positive RA patients from the North American Rheumatoid Arthritis Consortium (NARAC) who had radiographic data available were used for the replication study.
RESULTS: The TT and CC/CG genotypes of 2 single-nucleotide polymorphisms, rs4810485 (CD40) and rs42041 (CDK6), respectively, were associated with a higher rate of joint destruction in ACPA-positive RA patients (P=0.003 and P=0.012, respectively), with rs4810485 being significant after Bonferroni correction for multiple testing. The association of the CD40 minor allele with the rate of radiographic progression was replicated in the NARAC cohort (P=0.021).
CONCLUSION: A polymorphism in the CD40 locus is associated with the rate of joint destruction in patients with ACPA-positive RA. Our findings provide one of the first non-HLA-related genetic severity factors that has been replicated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644859      PMCID: PMC3121053          DOI: 10.1002/art.24721

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology.

Authors:  Eric M Jacobson; Erlinda Concepcion; Taiji Oashi; Yaron Tomer
Journal:  Endocrinology       Date:  2005-02-24       Impact factor: 4.736

2.  Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients.

Authors:  Annette H M van der Helm-van Mil; M Kern; Peter K Gregersen; Tom W J Huizinga
Journal:  Arthritis Rheum       Date:  2006-06

3.  CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.

Authors:  Hak-Yong Lee; Hyun-Soon Jeon; Eun-Kyung Song; Myung-Kwan Han; Sung-Il Park; Sang-Il Lee; Hee-Jin Yun; Jung-Ryul Kim; Jong-Suk Kim; Yong-Chul Lee; Sung-Il Kim; Hang-Rae Kim; Jin-Young Choi; Insoo Kang; Ho-Youn Kim; Wan-Hee Yoo
Journal:  Arthritis Rheum       Date:  2006-06

4.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

5.  Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage.

Authors:  L R Lard; M Boers; A Verhoeven; K Vos; H Visser; J M W Hazes; A H Zwinderman; G M T Schreuder; F C Breedveld; R R P De Vries; S van der Linden; E Zanelli; T W J Huizinga
Journal:  Arthritis Rheum       Date:  2002-04

6.  Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation.

Authors:  M J Yellin; S Winikoff; S M Fortune; D Baum; M K Crow; S Lederman; L Chess
Journal:  J Leukoc Biol       Date:  1995-08       Impact factor: 4.962

7.  TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.

Authors:  Robert M Plenge; Mark Seielstad; Leonid Padyukov; Annette T Lee; Elaine F Remmers; Bo Ding; Anthony Liew; Houman Khalili; Alamelu Chandrasekaran; Leela R L Davies; Wentian Li; Adrian K S Tan; Carine Bonnard; Rick T H Ong; Anbupalam Thalamuthu; Sven Pettersson; Chunyu Liu; Chao Tian; Wei V Chen; John P Carulli; Evan M Beckman; David Altshuler; Lars Alfredsson; Lindsey A Criswell; Christopher I Amos; Michael F Seldin; Daniel L Kastner; Lars Klareskog; Peter K Gregersen
Journal:  N Engl J Med       Date:  2007-09-05       Impact factor: 91.245

8.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

Review 9.  The Leiden Early Arthritis Clinic.

Authors:  J van Aken; J H van Bilsen; C F Allaart; T W Huizinga; F C Breedveld
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

10.  Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13.

Authors:  Anne Barton; Wendy Thomson; Xiayi Ke; Steve Eyre; Anne Hinks; John Bowes; Darren Plant; Laura J Gibbons; Anthony G Wilson; Deborah E Bax; Ann W Morgan; Paul Emery; Sophia Steer; Lynne Hocking; David M Reid; Paul Wordsworth; Pille Harrison; Jane Worthington
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

View more
  32 in total

1.  A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis.

Authors:  Wenfeng Tan; Hui Wu; Jian Zhao; Lezlie A Derber; David M Lee; Nancy A Shadick; Doyt L Conn; Edwin A Smith; Vivian H Gersuk; Gerald T Nepom; Larry W Moreland; Daniel E Furst; Susan D Thompson; Beth L Jonas; V Michael Holers; David N Glass; Pojen P Chen; S Louis Bridges; Michael E Weinblatt; Harold E Paulus; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2010-10

2.  Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

Authors:  Jing Shi; Rachel Knevel; Parawee Suwannalai; Michael P van der Linden; George M C Janssen; Peter A van Veelen; Nivine E W Levarht; Annette H M van der Helm-van Mil; Anthony Cerami; Tom W J Huizinga; Rene E M Toes; Leendert A Trouw
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

3.  C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis.

Authors:  Munitta Muthana; Sarah Hawtree; Adam Wilshaw; Eimear Linehan; Hannah Roberts; Sachin Khetan; Gbadebo Adeleke; Fiona Wright; Mohammed Akil; Ursula Fearon; Douglas Veale; Barbara Ciani; Anthony G Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-27       Impact factor: 11.205

4.  NF-κB and Rheumatoid Arthritis: Will Understanding Genetic Risk Lead to a Therapeutic Reward?

Authors:  Robert Scheinman
Journal:  For Immunopathol Dis Therap       Date:  2013-04-01

5.  The PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis.

Authors:  J A B van Nies; R Knevel; N Daha; M P M van der Linden; P K Gregersen; M Kern; S le Cessie; J J Houwing-Duistermaat; T W J Huizinga; R E M Toes; A H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2010-04-13       Impact factor: 19.103

Review 6.  Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.

Authors:  Michael Croft; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

7.  Association of CD40 Gene Polymorphisms with Susceptibility to Neuromyelitis Optica Spectrum Disorders.

Authors:  Ziyan Shi; Qin Zhang; Hongxi Chen; Xiaohui Miao; Ju Liu; Zhiyun Lian; Huiru Feng; Hongyu Zhou
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

Review 8.  Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics.

Authors:  Yaron Tomer
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

9.  A comprehensive molecular interaction map for rheumatoid arthritis.

Authors:  Gang Wu; Lisha Zhu; Jennifer E Dent; Christine Nardini
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

10.  Rheumatoid arthritis: GWAS or TMI?

Authors:  Bruce N Cronstein
Journal:  Genome Med       Date:  2009-10-27       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.